Botox for migraines treatment introduced in the UAE

Published: Updated:
Enable Read mode
100% Font Size

Chronic migraines can be treated using Botox according to an international study, the UAE has subsequently become one of the first countries in the region to sanction the treatment, reported Gulf News on Saturday.

The symptoms of a migraine include blurred vision, sensitivity to sound and light and nausea.

Dr. Susan Ebrahim Noori, neurology consultant and multiple sclerosis specialist at University Hospital Sharjah, explained how the Botox treatment works, in an interview with Gulf News.

“Treating migraine headaches by Botox involves injecting Botox into 31 sites in the head, neck and shoulder. This treatment is approved by a protocol issued by the U.S. Food and Drug Administration, based on the results of studies that showed evidence of improvement through its use,” she said.

“Sufferers reported relief from symptoms about seven to ten days after being injected” she added.

“The treatment works for up to three months” Noori told Gulf news.

The treatment was tested over a period of 56 weeks in a study that was done across six countries including the U.S., Canada and several European countries. The study involved 1,834 people.

After studying the results, professionals in the UAE decided that “Botox is a safe, complication-free treatment that has been proven successful in curing diseases such as muscle stiffness caused by a stroke, spinal cord injuries, migraine facial paralysis and inconsistency in hand muscle movement,” Noori concluded to Gulf news.

Top Content Trending